Chemical peel before & after treatment instructions
before & after treatment instructions
Please follow the instructions below to prepare for your treatment. Your compliance with your
pre- and post-peel instructions will greatly affect the outcome of your treatment.
1. Refrain from these activities for 7 days prior to your treatment:
Do not have another treatment, unless recommended.
Avoid any skin irritants, including retinoids and retinol, glycolic and salicylic acids, benzoyl peroxide, astringents and Vitamin C.
Do not wax, tweeze or use depilatory creams.
2. Do not schedule a procedure if you are pregnant or think you are pregnant.
3. Continue to use other skin care products, including a hydroquinone or lightening
At home, have benadryl and aspirin or Tylenol available.
Day 1: Rinse off the peel at ______ . using your fingertips and cool water. Do not apply
anything else to the skin. Your skin will appear sunburned today and will continue to look
redder as the day continues. It will begin to feel tight like you have a sunburn. You may also
experience itching or mild burning as the peel penetrates deeper into the skin. You can help to
alleviate this sensation by taking benadryl or zantac (for itching) and aspirin or Tylenol (for
discomfort), as needed. You will want to avoid wearing makeup or tight fitting glasses for the
first day or two. Pressure from the nosepiece may cause deepening of the peel in that area.
Day 2: Your skin will continue to feel very tight. The top layers of skin are dehydrating. You
will look like you have an uneven sunburn/tan. You may still feel comfortable in public today.
By the end of the day your skin may begin to flake, usually starting between your eyes,
around your mouth and nose. Sun-damaged spots may turn darker prior to peeling. Rinse
your face with water today. Use only your hands. Cool or tepid water generally feels best. Do
not use a cleanser or moisturizer. DO NOT PEEL THE SKIN. If any area is irritated, you may
apply Skin Medica’s TNS and/or Ceraminde cream, mild hydrocortisone cream or Aquaphor.
Day 3: Your skin will flake, peel and feel very tight today. DO NOT peel the skin at any time. If you were to peel skin that is not ready to come off, you could cause scarring. You may carefully use manicure scissors to clip any hanging skin. Today and tomorrow you may want to avoid making social plans. Begin using a gentle cleanser today, such as Skin Medica’s Sensitive Skin Cleanser or Facial Cleanser, and a strong hydrating cream, such as Skin Medica’s Dermal Repair or Ceramind cream. Do NOT use SPF or retinoids, retinol, acids, astringents or Vitamin C. You must completely avoid the sun during this time. This is the last day you should use hydrocortisone to irritated areas. Day 4: The majority of peeling takes place between days 3 and 4. Continue with cleansing and moisturizing. Some areas will have completely peeled and other areas may have not peeled at all. This is normal. Day 5: Your skin may be tender for a few days. You may exfoliate the skin with a gentle scrub, such as Skin Medica’s Skin Polisher, to remove any remaining skin that has not peeled. Continue to avoid sun exposure for the next two weeks. You may begin to wear SPF, but only if it is not irritating. Day 7: You may be seen today for a SilkPeel™ treatment to remove the remaining flaking skin. Ease back into your skin care products. Wear sunscreen at all times following your Silk Peel™ treatment. Between week 1 and week 2: You may resume waxing, tweezing or depilatory creams during this week. By the end of the second week you should be able to tolerate glycolic, salicylic, Vitamin C, and retinol or retinoid products. You will notice your skin is pink for about one more week. Skin Medica offers a line of products containing TNS, a compound which promotes skin healing and is a great addition to your post peel regimen. Remember, daily sunscreen with an SPF of 30 is recommended to maintain your improved skin. If you have questions at any time, please call the office at 614-799-5100.
CONSULTATION WITH TARGET PATIENT GROUPS - MEETING THE REQUIREMENTS OF ARTICLE 59(3) WITHOUT THE NEED FOR A FULL TEST - RECOMMENDATIONS FOR BRIDGING Revision 1, April 2009 1. INTRODUCTION Guidance has already been issued from the CMD(h) which indicates that although all package leaflets (PLs) for medicines must reflect the results of consultation with target patient
Clinical Practice Guidelines by the InfectiousDiseases Society of America for the Treatment ofMethicillin-Resistant Staphylococcus aureusInfections in Adults and Children: ExecutiveSummaryCatherine Liu,1 Arnold Bayer,3,5 Sara E. Cosgrove,6 Robert S. Daum,7 Scott K. Fridkin,8 Rachel J. Gorwitz,9Sheldon L. Kaplan,10 Adolf W. Karchmer,11 Donald P. Levine,12 Barbara E. Murray,14 Michael J. Rybak,12,1